Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0009
-0.0001 (-10.00%)
Jul 8, 2026, 3:14 PM EST
Halberd Market Cap
Halberd has a market cap or net worth of $747.3 thousand as of July 8, 2026. Its market cap has decreased by -46.76% in one year.
Market Cap
747.30K
Enterprise Value
n/a
Revenue
6.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 747.30K, a decrease of -71.32%. That is a compound annual growth rate of -7.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 672.57K | -36.61% |
| Dec 31, 2025 | 1.06M | -58.29% |
| Dec 31, 2024 | 2.54M | -11.40% |
| Dec 29, 2023 | 2.87M | -4.05% |
| Dec 30, 2022 | 2.99M | -62.35% |
| Dec 31, 2021 | 7.95M | -4.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 1.09M |
| Abpro Holdings | 1.07M |
| Lyra Therapeutics | 1.06M |
| ZyVersa Therapeutics | 893.43K |
| Emmaus Life Sciences | 801.62K |
| Agentix | 801.34K |
| Burzynski Research Institute | 719.02K |
| SQZ Biotechnologies Company | 707.79K |